Spectral Medical Inc. (OTCMKTS:EDTXF) Short Interest Down 13.7% in January

Spectral Medical Inc. (OTCMKTS:EDTXF) was the target of a large decline in short interest in January. As of January 31st, there was short interest totalling 58,000 shares, a decline of 13.7% from the January 15th total of 67,200 shares. Based on an average daily volume of 5,500 shares, the short-interest ratio is currently 10.5 days.

Spectral Medical Stock Performance

OTCMKTS EDTXF traded up $0.02 on Monday, reaching $0.45. 15,009 shares of the stock traded hands, compared to its average volume of 3,488. The company has a fifty day moving average price of $0.37 and a 200-day moving average price of $0.42. The company has a market cap of $126.52 million, a price-to-earnings ratio of -6.36 and a beta of 0.87. Spectral Medical has a 12 month low of $0.29 and a 12 month high of $0.55.

Spectral Medical Company Profile

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.